论文部分内容阅读
1993～1994年,我们采用冠心胶囊治疗冠心病52例,疗效较好,现报告如下。 一般资料:根据1979年WHO诊断标准,将102例冠心病患者随机分为两组,两组性别、年龄(35～76岁)及病情无差异。其中心肌梗塞18例,冠心病并心衰20例,冠心病心绞痛64例(治疗组31例,对照组33例);心电图异常72例(治疗组38例,对照组34例),其中68例ST-T异常,4例束支传导阻滞。 治疗方法:对照组给予常规治疗;治疗组在常规洽疗的基础上加用冠心胶囊。该药由熊胆、黄
From 1993 to 1994, we used coronary heart capsule coronary heart disease in 52 cases, the effect is better, are as follows. General information: According to the 1979 WHO diagnostic criteria, 102 patients with coronary heart disease were randomly divided into two groups, the two groups of gender, age (35 to 76 years old) and the disease was no difference. There were 18 cases of myocardial infarction, 20 cases of coronary heart disease and heart failure, 64 cases of coronary heart disease angina pectoris (31 cases in the treatment group and 33 cases in the control group), 72 cases of abnormal electrocardiogram (38 cases in the treatment group and 34 cases in the control group) ST-T abnormalities, 4 cases of bundle branch block. Treatment: control group given conventional treatment; treatment group in the conventional treatment based on the use of coronary heart capsule. The drug by the bear gall, yellow